Posted on: October 20, 2016
Robert Ashton M.D., Executive Vice President of Healthcare Operations, Cambridge Therapeutic Technologies
Medication adherence is a major problem impacting the US population and health care system: up to 50% of patients do not take their medication as prescribed; 125,000 Americans die annually due to poor medication adherence; and nonadherence results in $100 billion in excess hospitalizations and $290 billion in overall costs. Addressing this issue is critical to the future of health care costs and patient outcomes.
The issues surrounding medication adherence are complex and multifactorial. Cambridge Therapeutic Technologies (CTT) has created an effective solution that disrupts the current system with a streamlined patient-centric approach.
Unlock the full article by signing up for a FREE Guest Membership